Innoveren Scientific Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Michael Yurkowsky
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 2.9yrs |
| CEO ownership | n/a |
| Management average tenure | 2.9yrs |
| Board average tenure | 4.3yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2023 | n/a | n/a | -US$3m |
| Jun 30 2023 | n/a | n/a | -US$5m |
| Mar 31 2023 | n/a | n/a | -US$8m |
| Dec 31 2022 | US$508k | US$180k | -US$10m |
| Sep 30 2022 | n/a | n/a | -US$10m |
| Jun 30 2022 | n/a | n/a | -US$8m |
| Mar 31 2022 | n/a | n/a | -US$7m |
| Dec 31 2021 | US$372k | US$15k | -US$5m |
| Sep 30 2021 | n/a | n/a | -US$6m |
| Jun 30 2021 | n/a | n/a | -US$1m |
| Mar 31 2021 | n/a | n/a | -US$6m |
| Dec 31 2020 | n/a | n/a | -US$7m |
| Sep 30 2020 | n/a | n/a | -US$26m |
| Jun 30 2020 | n/a | n/a | -US$33m |
| Mar 31 2020 | n/a | n/a | -US$32m |
| Dec 31 2019 | US$5k | n/a | -US$33m |
Compensation vs Market: Insufficient data to establish whether Michael's total compensation is reasonable compared to companies of similar size in the US market.
Compensation vs Earnings: Michael's compensation has increased whilst the company is unprofitable.
CEO
Michael Yurkowsky (52 yo)
2.9yrs
Tenure
US$507,787
Compensation
Mr. Michael W. Yurkowsky serves as Chief Executive Officer at Innoveren Scientific Inc. (formerly known as H-CYTE, Inc.) since December 6, 2021. He serves as Chairman of Deverra Therapeutics inc and serves...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 2.9yrs | US$507.79k | no data | |
| Chief Financial Officer | 5.8yrs | US$200.00k | no data | |
| Chief Scientific Officer | 2.8yrs | US$252.00k | no data | |
| Controller & Principal Accounting Officer | no data | no data | no data |
2.9yrs
Average Tenure
49.5yo
Average Age
Experienced Management: IVRN's management team is considered experienced (2.9 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 5.8yrs | US$507.79k | no data | |
| Independent Director | 2.8yrs | no data | no data | |
| Independent Chairman of the Board | 5.8yrs | no data | no data | |
| Independent Director | 2.8yrs | no data | no data |
4.3yrs
Average Tenure
61yo
Average Age
Experienced Board: IVRN's board of directors are considered experienced (4.3 years average tenure).